BPC-157 Arginate vs Thymosin Beta-4 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
BPC-157 Arginate is the arginine salt form of BPC-157, identical in the GEPPPGKPADDAGLV peptide sequence but with improved water solubility, aqueous stability, and oral bioavailability. The arginate counterion buffers GI microenvironmental pH, reducing acid-catalyzed peptide degr...
Calculate BPC-157 Arginate dose →Thymosin Beta-4 (TB-4) is the full-length 43-amino acid actin-sequestering peptide from which the commonly used research fragment TB-500 (residues 17-23, LKKTETQ) is derived. TB-4 is the most abundant thymosin-family protein in virtually all mammalian cells, where it maintains th...
Calculate Thymosin Beta-4 dose →| Parameter | BPC-157 Arginate | Thymosin Beta-4 |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Extensively Studied | Extensively Studied |
| Half-Life | 4–6 hours | ~30-60 min (plasma) |
| Typical Dose | 250–500 µg | 1.5-2.5 mg, 2-3x/week |
| Frequency | Once or twice daily | 2-3 times per week |
| Route | Oral / Subcutaneous | Subcutaneous, IV, Topical, Intranasal |
| FDA Status | Not Approved | Phase II |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.